Articles producció científica> Medicina i Cirurgia

SEA 2022 Standards for Global Control of Cardiovascular Risk

  • Dades identificatives

    Identificador: imarina:9244538
    Autors:
    Mostaza JMPintó XArmario PMasana LReal JTValdivielso PArrobas-Velilla TBaeza-Trinidad RCalmarza PCebollada JCivera-Andrés MCuende Melero JIDíaz-Díaz JLFernández Pardo JGuijarro CJericó CLaclaustra MLahoz CLópez-Miranda JMartínez-Hervás SMuñiz-Grijalvo OPáramo JAPascual VPedro-Botet JPérez-Martínez PPlana NPuzo JSánchez Chaparro MVila L
    Resum:
    One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
  • Altres:

    Autor segons l'article: Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuende Melero JI; Díaz-Díaz JL; Fernández Pardo J; Guijarro C; Jericó C; Laclaustra M; Lahoz C; López-Miranda J; Martínez-Hervás S; Muñiz-Grijalvo O; Páramo JA; Pascual V; Pedro-Botet J; Pérez-Martínez P; Plana N; Puzo J; Sánchez Chaparro M; Vila L
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Masana Marín, Luis / Plana Gil, Núria
    Paraules clau: Smoking Dyslipidaemia Diabetes Coronary-artery calcium Cardiovascular prevention Atrial fibrillation Arterial hypertension task-force spanish society smoking familial hypercholesterolemia dyslipidaemia diabetes consensus document clinical-practice blood-pressure atrial-fibrillation atrial fibrillation arteriosclerosis sea arterial hypertension american-college
    Resum: One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
    Àrees temàtiques: Pharmacology (medical) Peripheral vascular disease Medicina iii Medicina i Cardiology and cardiovascular medicine
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: luis.masana@urv.cat
    Identificador de l'autor: 0000-0002-0789-4954
    Data d'alta del registre: 2024-08-24
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Clinica E Investigacion En Arteriosclerosis. 34 (3): 130-179
    Referència de l'ítem segons les normes APA: Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuend (2022). SEA 2022 Standards for Global Control of Cardiovascular Risk. Clinica E Investigacion En Arteriosclerosis, 34(3), 130-179. DOI: 10.1016/j.arteri.2021.11.003
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2022
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cardiology and Cardiovascular Medicine,Peripheral Vascular Disease,Pharmacology (Medical)
    Smoking
    Dyslipidaemia
    Diabetes
    Coronary-artery calcium
    Cardiovascular prevention
    Atrial fibrillation
    Arterial hypertension
    task-force
    spanish society
    smoking
    familial hypercholesterolemia
    dyslipidaemia
    diabetes
    consensus document
    clinical-practice
    blood-pressure
    atrial-fibrillation
    atrial fibrillation
    arteriosclerosis sea
    arterial hypertension
    american-college
    Pharmacology (medical)
    Peripheral vascular disease
    Medicina iii
    Medicina i
    Cardiology and cardiovascular medicine
  • Documents:

  • Cerca a google

    Search to google scholar